Ultram and Pancytopenia - a phase IV clinical study of FDA data
Summary:
Pancytopenia is reported as a side effect among people who take Ultram (tramadol hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zofran, and have Nausea.
The phase IV clinical study analyzes which people have Pancytopenia when taking Ultram. It is created by eHealthMe based on reports of 26,802 people who have side effects when taking Ultram from the FDA, and is updated regularly.
What is Ultram?
Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.
What is Pancytopenia?
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets) is found to be associated with 1,793 drugs and 2,431 conditions by eHealthMe. Check the latest studies of Pancytopenia.
26,802 people reported to have side effects when taking Ultram.
Among them, 114 people (0.43%) have Pancytopenia.
Among these 114 people:
How long have people been on Ultram when they have Pancytopenia? *
What is the gender of people who have Pancytopenia when taking Ultram? *
What is the age of people who have Pancytopenia when taking Ultram? *
What are other drugs people take besides Ultram? *
What are other side effects people have besides Pancytopenia? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Ultram and have Pancytopenia?
- Check whether Pancytopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ultram:
- Ultram (28,425 reports)
Pancytopenia treatments and more:
- Pancytopenia (69,290 reports)
How severe was Pancytopenia and when was it recovered:
Expand to all the drugs that have ingredients of tramadol hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ultram:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Pancytopenia:
- Pancytopenia (1,793 drugs)
Browse all the conditions that are associated with Pancytopenia:
- Pancytopenia (2,431 conditions)
Related publications that referenced our studies
- Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
- Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Ultram) and Ultram (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Midazolam Hydrochloride cause Diastolic Dysfunction? - 4 seconds ago
- Drug interactions of Hydroxyurea and Acyclovir - 27 seconds ago
- Midol vs. Paracetamol, side effect and effectiveness comparison - 30 seconds ago
- Bronchitis and Infection - 38 seconds ago
- Psoriasis and Leukocytosis - 45 seconds ago
- Could Medroxyprogesterone Acetate cause Hair Loss? - 55 seconds ago
- Drug interactions of Rabeprazole and Guaifenesin - a minute ago
- Drug interactions of Clobazam and Aromasin - a minute ago
- Drug interactions of Vitamins and Turalio - a minute ago
- Deep Venous Thrombosis and Weight Decreased - a minute ago